{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:55Z","timestamp":1774538695876,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.contraception.2008.08.011","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T05:07:17Z","timestamp":1226984837000},"page":"15-23","source":"Crossref","is-referenced-by-count":42,"title":["The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters"],"prefix":"10.1016","volume":"79","author":[{"given":"Ulrich H.","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Sudik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.08.011_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.contraception.2008.08.011_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ije\/19.4.931","article-title":"Oral contraceptive estrogen and progestin potencies and the incidence of deep venous thromboembolism","volume":"19","author":"Gerstman","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.contraception.2008.08.011_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2008.08.011_bib4","first-page":"91","article-title":"Venous thromboembolism in relation to oral contraceptive use","volume":"69","author":"Helmrich","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.08.011_bib5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.08.011_bib6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.08.011_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2008.08.011_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.08.011_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2008.08.011_bib10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database","volume":"14","author":"Todd","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2008.08.011_bib11","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0010-7824(00)00148-7","article-title":"Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism","volume":"62","author":"Winkler","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(93)90141-S","article-title":"Hemostatic and metabolic effects of lowering the ethinyl\u2013estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel","volume":"48","author":"Basdevant","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4065\/72.3.235","article-title":"Lipids and lipoproteins in women","volume":"72","author":"O'Brien","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2008.08.011_bib14","first-page":"14","article-title":"The rationale for a wider range of progestogens","volume":"3","author":"Skouby","year":"2000","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2008.08.011_bib15","first-page":"180","article-title":"Clinical relevance of plasma lipid changes during use of new low-dose oral contraceptives","volume":"7","author":"Gaspard","year":"1991","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2008.08.011_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14034940510032239","article-title":"Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women","volume":"34","author":"Graff-Iversen","year":"2006","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.contraception.2008.08.011_bib17","first-page":"29","article-title":"Mortality among oral contraceptive users","volume":"70","author":"Porter","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.08.011_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(03)13907-4","article-title":"Mortality in relation to oral contraceptive use and cigarette smoking","volume":"362","author":"Vessey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.08.011_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0010-7824(89)90127-3","article-title":"Oral contraceptives and lipids and lipoproteins: Part I \u2014 Variations in mean levels by oral contraceptive type","volume":"40","author":"Burkman","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2008-1026660","article-title":"Auswirkungen eines chlormadinonazetathaltigen ovulationshemmers auf androgenisierungserscheinungen sowie den leber-und fettstoffwechsel junger frauen","volume":"46","author":"Cirkel","year":"1986","journal-title":"Geburtsh u Frauenheilk"},{"key":"10.1016\/j.contraception.2008.08.011_bib21","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1345\/aph.19381","article-title":"The origin of the \u201cideal\u201d body weight equations","volume":"34","author":"Pai","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2008.08.011_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0010-7824(94)00010-T","article-title":"Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel","volume":"51","author":"Fotherby","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0010-7824(88)90003-0","article-title":"Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins","volume":"37","author":"Harvengt","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.08.011_bib25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9378(76)90058-2","article-title":"Serum prolactin concentrations in women treated with chlormadinone acetate","volume":"124","author":"Beck","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.08.011_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003495-200464070-00005","article-title":"Ethinylestradiol\/chlormadinone acetate","volume":"64","author":"Curran","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2008.08.011_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2008.08.011_bib28","first-page":"423","article-title":"Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate","volume":"41","author":"Charoenvisal","year":"1996","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.contraception.2008.08.011_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0010-7824(96)00006-6","article-title":"Changes in androgens during treatment with four low-dose contraceptives","volume":"53","author":"Coenen","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0010-7824(97)00010-3","article-title":"Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. UK Desogen Study Group","volume":"55","author":"Crook","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/13625180008500411","article-title":"Effect of a desogestrel-containing oral contraceptive on the skin","volume":"5","author":"Katz","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.08.011_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(02)00536-X","article-title":"A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties","volume":"67","author":"Schramm","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.08.011_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2008.08.011_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00041433-199608000-00008","article-title":"Insulin resistance and coronary heart disease","volume":"7","author":"Laakso","year":"1996","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.contraception.2008.08.011_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0010-7824(94)90051-5","article-title":"Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive","volume":"50","author":"Cachrimanidou","year":"1994","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2008.08.011_bib36","first-page":"92","article-title":"Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives","volume":"40","author":"Coenen","year":"1995","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2008.08.011_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-8981(87)90183-5","article-title":"The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone","volume":"165","author":"Meulenberg","year":"1987","journal-title":"Clin Chim Acta"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408004277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408004277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T10:17:49Z","timestamp":1557915469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408004277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0010782408004277"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.08.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}